June 4, 2019  |  Announcements

PRESS RELEASE: Beckman Coulter Life Sciences Acquires Cytobank

FOR IMMEDIATE RELEASE
BECKMAN COULTER LIFE SCIENCES ACQUIRES CYTOBANK

bcls-vert_1200(INDIANAPOLIS, INDIANA – June 4, 2019) – Beckman Coulter Life Sciences today announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.

More »

November 30, 2018  |  Announcements, Education, FlowSOM, Release Notes

Announcing: Cytobank 7.0 with FlowSOM

We are delighted to introduce our latest version of Cytobank.

flowsom_marketing5-1200px

Included in this release are many performance and interface improvements, as well as a notable new addition to our repertoire of integrated algorithms. As we continue to evolve and improve our platform in response to your needs and feedback, we also look to leaders in our field to expand our capabilities and bring high-level developments in bioinformatics to you in an approachable and easy-to-use way.
In this spirit, we introduce
FlowSOM in Cytobank More »

November 12, 2018  |  Announcements, Flow Cytometry, FlowSOM, Webinars

Free Webinar Nov 28th:
Intro to FlowSOM in Cytobank with Sofie van Gassen

Free FlowSOM Webinar Wednesday, November 28, 2018 SofieCircle
9:00 AM PST / 12:00 PM EST / 6:00 PM CET

FlowSOM in Cytobank is coming soon!

Sign up now to learn from our scientists and our special guest expert for our next live webinar.

FlowSOMNovember2018When it is released to all users on Cytobank later this month, the FlowSOM algorithm will speed time to analysis and quality of clustering with self-organizing maps (SOMs) that can reveal how all markers are behaving on all cells, and can detect subsets that might otherwise be missed. If you have a large study with many events per sample or many samples, FlowSOM enables you to include all your data in the analysis, instead of restrictively subsampling. Leveraging the power of the Cytobank cloud, users can scale their compute to run up to 90 million events through FlowSOM in only 3.5 hours More »

October 19, 2018  |  Announcements

Secure and Reliable Storage of Your Clinical Research Data in the Cloud

Screen Shot 2018-09-28 at 11.15.29 AMBy our guest blogger, Ken Stineman*, Ken is Cytobank’s Security Lead.

Cytobank is utilized by most of the top pharmaceutical companies, immunologically-driven biotech companies and many leading academic institutions for analyzing, storing and sharing complex cytometry data generated on their clinical trial specimens. These entities routinely perform rigorous assessments of our security and these complement the testing and evaluation we do in-house. More »

October 18, 2018  |  Announcements

Don’t Miss The 4th Sino-US Cytometry Workshop in China

Qianjun Zhang of Cytobank
Qianjun Zhang

ISAC’s Live Education Delivery Task Force will be hosting the fourth Sino-US Cytometry Workshop in Hangzhou, China October 24th-26th. Be sure to catch our very own Qianjun Zhang as she serves as co-host and speaker at the event. Her session, entitled “Big Data in Single Cell, high dimensional data analysis” will be on Thursday, October 25th at 15:30 local time.

cyobankarrow40x40See the Program Schedule More »

August 1, 2018  |  Announcements, Press Releases

PRESS RELEASE: Cytobank Awarded NIH Grant to Scale its Cloud-based Machine Learning Platform for Accelerating Immunotherapy Translational Research

 Novel data analysis methods will automate biomarker discovery
to predict patient response in clinical trials

Mountain View, Calif. – August 1, 2108 – Cytobank has beenNIHLogo awarded a $1.3M Phase II SBIR grant from the NIH to scale and add more machine learning algorithms to its popular cloud-based informatics platform. In use at many leading academic institutions and the top ten global pharmaceutical companies, Cytobank’s research platform enables faster, more comprehensive analysis of the high-dimensional single cell datasets captured in immunotherapy clinical trials. There are greater than 1,000 active clinical trials for immunotherapies in oncology alone. More »